150 related articles for article (PubMed ID: 8365480)
1. Staurosporine-related compounds, K252a and UCN-01, inhibit both cPKC and nPKC.
Mizuno K; Saido TC; Ohno S; Tamaoki T; Suzuki K
FEBS Lett; 1993 Sep; 330(2):114-6. PubMed ID: 8365480
[TBL] [Abstract][Full Text] [Related]
2. UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily.
Mizuno K; Noda K; Ueda Y; Hanaki H; Saido TC; Ikuta T; Kuroki T; Tamaoki T; Hirai S; Osada S
FEBS Lett; 1995 Feb; 359(2-3):259-61. PubMed ID: 7867810
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.
Seynaeve CM; Kazanietz MG; Blumberg PM; Sausville EA; Worland PJ
Mol Pharmacol; 1994 Jun; 45(6):1207-14. PubMed ID: 8022414
[TBL] [Abstract][Full Text] [Related]
4. Expression of four protein kinase C isoforms in rat fibroblasts. Differential alterations in ras-, src-, and fos-transformed cells.
Borner C; Guadagno SN; Hsiao WW; Fabbro D; Barr M; Weinstein IB
J Biol Chem; 1992 Jun; 267(18):12900-10. PubMed ID: 1618788
[TBL] [Abstract][Full Text] [Related]
5. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.
Rüegg UT; Burgess GM
Trends Pharmacol Sci; 1989 Jun; 10(6):218-20. PubMed ID: 2672462
[No Abstract] [Full Text] [Related]
6. Protein kinase inhibitors and blood pressure control in spontaneously hypertensive rats.
Buchholz RA; Dundore RL; Cumiskey WR; Harris AL; Silver PJ
Hypertension; 1991 Jan; 17(1):91-100. PubMed ID: 1986986
[TBL] [Abstract][Full Text] [Related]
7. The effect of putative protein kinase C inhibitors, K252a and staurosporine, on the human neutrophil respiratory burst activated by both receptor stimulation and post-receptor mechanisms.
Twomey B; Muid RE; Dale MM
Br J Pharmacol; 1990 Aug; 100(4):819-25. PubMed ID: 2169942
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C zeta and eta in murine epidermis. TPA induces down-regulation of PKC eta but not PKC zeta.
Gschwendt M; Leibersperger H; Kittstein W; Marks F
FEBS Lett; 1992 Jul; 307(2):151-5. PubMed ID: 1644168
[TBL] [Abstract][Full Text] [Related]
9. Expression of protein kinase C isozymes that are required for chondrogenesis of chick limb bud mesenchymal cells.
Choi B; Chun JS; Lee YS; Sonn JK; Kang SS
Biochem Biophys Res Commun; 1995 Nov; 216(3):1034-40. PubMed ID: 7488176
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
Courage C; Budworth J; Gescher A
Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
Ward NE; O'Brian CA
Mol Pharmacol; 1992 Feb; 41(2):387-92. PubMed ID: 1538715
[TBL] [Abstract][Full Text] [Related]
12. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
Takahashi I; Kobayashi E; Nakano H; Murakata C; Saitoh H; Suzuki K; Tamaoki T
J Pharmacol Exp Ther; 1990 Dec; 255(3):1218-21. PubMed ID: 2262903
[TBL] [Abstract][Full Text] [Related]
13. K252a is a potent and selective inhibitor of phosphorylase kinase.
Elliott LH; Wilkinson SE; Sedgwick AD; Hill CH; Lawton G; Davis PD; Nixon JS
Biochem Biophys Res Commun; 1990 Aug; 171(1):148-54. PubMed ID: 2393389
[TBL] [Abstract][Full Text] [Related]
14. The role of protein kinase C isoenzymes in the regulation of calcineurin activity in human peripheral blood mononuclear cells.
Szíjgyártó Z; Szucs K; Kovács I; Zákány R; Sipka S; Gergely P
Int J Mol Med; 2007 Sep; 20(3):359-64. PubMed ID: 17671741
[TBL] [Abstract][Full Text] [Related]
15. Effects of staurosporine on cell morphology, expression of the proenkephalin gene and the secretion of [Met5]-enkephalin in bovine adrenal medullary chromaffin cells.
Suh HW; McMillian MK; Hudson PM; Hong JS
Biol Signals; 1994; 3(5):247-58. PubMed ID: 7704105
[TBL] [Abstract][Full Text] [Related]
16. Activation of novel protein kinases C delta and C epsilon upon mitogenic stimulation of quiescent rat 3Y1 fibroblasts.
Ohno S; Mizuno K; Adachi Y; Hata A; Akita Y; Akimoto K; Osada S; Hirai S; Suzuki K
J Biol Chem; 1994 Jul; 269(26):17495-501. PubMed ID: 8021256
[TBL] [Abstract][Full Text] [Related]
17. Modulation of apoptosis in rat thymocytes by analogs of staurosporine: lack of direct association with inhibition of protein kinase C.
Harkin ST; Cohen GM; Gescher A
Mol Pharmacol; 1998 Oct; 54(4):663-70. PubMed ID: 9765509
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine.
Courage C; Bradder SM; Jones T; Schultze-Mosgau MH; Gescher A
Int J Cancer; 1997 Nov; 73(5):763-8. PubMed ID: 9398059
[TBL] [Abstract][Full Text] [Related]
19. A role for protein kinase C-alpha in zymosan-stimulated eicosanoid synthesis in mouse peritoneal macrophages.
Huwiler A; Pfeilschifter J
Eur J Biochem; 1993 Oct; 217(1):69-75. PubMed ID: 8223588
[TBL] [Abstract][Full Text] [Related]
20. Potent and specific inhibitors of protein kinase C of microbial origin.
Tamaoki T; Nakano H
Biotechnology (N Y); 1990 Aug; 8(8):732-5. PubMed ID: 1370017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
